-
Je něco špatně v tomto záznamu ?
Joint statement for assessing and managing high blood pressure in children and adolescents: Chapter 1. How to correctly measure blood pressure in children and adolescents
E. Lurbe, G. Mancia, J. Calpe, D. Drożdż, S. Erdine, F. Fernandez-Aranda, A. Hadjipanayis, PF. Hoyer, A. Jankauskiene, S. Jiménez-Murcia, M. Litwin, A. Mazur, D. Pall, T. Seeman, MD. Sinha, G. Simonetti, S. Stabouli, E. Wühl
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2013
Free Medical Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
- Publikační typ
- časopisecké články MeSH
The joint statement is a synergistic action between HyperChildNET and the European Academy of Pediatrics about the diagnosis and management of hypertension in youth, based on the European Society of Hypertension Guidelines published in 2016 with the aim to improve its implementation. The first and most important requirement for the diagnosis and management of hypertension is an accurate measurement of office blood pressure that is currently recommended for screening, diagnosis, and management of high blood pressure in children and adolescents. Blood pressure levels should be screened in all children starting from the age of 3 years. In those children with risk factors for high blood pressure, it should be measured at each medical visit and may start before the age of 3 years. Twenty-four-hour ambulatory blood pressure monitoring is increasingly recognized as an important source of information as it can detect alterations in circadian and short-term blood pressure variations and identify specific phenotypes such as nocturnal hypertension or non-dipping pattern, morning blood pressure surge, white coat and masked hypertension with prognostic significance. At present, home BP measurements are generally regarded as useful and complementary to office and 24-h ambulatory blood pressure for the evaluation of the effectiveness and safety of antihypertensive treatment and furthermore remains more accessible in primary care than 24-h ambulatory blood pressure. A grading system of the clinical evidence is included.
Analog Devices Inc Paterna Spain
CIBER Fisiopatología de la Obesidad y Nutrición Instituto de Salud Carlos 3 Madrid Spain
Department of Clinical Sciences University of Barcelona Barcelona Spain
Department of Medical Clinical Pharmacology University of Debrecen Debrecen Hungary
Department of Medicine University of Debrecen Debrecen Hungary
Department of Paediatrics Larnaca General Hospital Larnaca Cyprus
Department of Pediatric Consorcio Hospital General University of Valencia Valencia Spain
Department of Pediatrics 2 University Hospital Essen Essen Germany
Department of Pediatrics University Hospital Ostrava Ostrava Czechia
Division of Pediatric Nephrology University Children's Hospital Charles University Prague Czechia
Institute of Medical Sciences Medical College Rzeszów University Rzeszow Poland
Institute of Pediatrics of Southern Switzerland Ente Ospedaliero Cantonale Bellinzona Switzerland
Istanbul University Cerrahpaşa Cerrahpaşa Faculty of Medicine Istanbul Turkey
Pediatric Center Institute of Clinical Medicine Vilnius University Vilnius Lithuania
School of Medicine European University Cyprus Nicosia Cyprus
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010011
- 003
- CZ-PrNML
- 005
- 20230721095347.0
- 007
- ta
- 008
- 230707s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fped.2023.1140357 $2 doi
- 035 __
- $a (PubMed)37138561
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Lurbe, Empar $u CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain $u Department of Pediatric, Consorcio Hospital General, University of Valencia, Valencia, Spain
- 245 10
- $a Joint statement for assessing and managing high blood pressure in children and adolescents: Chapter 1. How to correctly measure blood pressure in children and adolescents / $c E. Lurbe, G. Mancia, J. Calpe, D. Drożdż, S. Erdine, F. Fernandez-Aranda, A. Hadjipanayis, PF. Hoyer, A. Jankauskiene, S. Jiménez-Murcia, M. Litwin, A. Mazur, D. Pall, T. Seeman, MD. Sinha, G. Simonetti, S. Stabouli, E. Wühl
- 520 9_
- $a The joint statement is a synergistic action between HyperChildNET and the European Academy of Pediatrics about the diagnosis and management of hypertension in youth, based on the European Society of Hypertension Guidelines published in 2016 with the aim to improve its implementation. The first and most important requirement for the diagnosis and management of hypertension is an accurate measurement of office blood pressure that is currently recommended for screening, diagnosis, and management of high blood pressure in children and adolescents. Blood pressure levels should be screened in all children starting from the age of 3 years. In those children with risk factors for high blood pressure, it should be measured at each medical visit and may start before the age of 3 years. Twenty-four-hour ambulatory blood pressure monitoring is increasingly recognized as an important source of information as it can detect alterations in circadian and short-term blood pressure variations and identify specific phenotypes such as nocturnal hypertension or non-dipping pattern, morning blood pressure surge, white coat and masked hypertension with prognostic significance. At present, home BP measurements are generally regarded as useful and complementary to office and 24-h ambulatory blood pressure for the evaluation of the effectiveness and safety of antihypertensive treatment and furthermore remains more accessible in primary care than 24-h ambulatory blood pressure. A grading system of the clinical evidence is included.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mancia, Giuseppe $u University of Milano-Bicocca, Milan, Italy
- 700 1_
- $a Calpe, Javier $u Analog Devices, Inc., Paterna, Spain
- 700 1_
- $a Drożdż, Dorota $u Department of Pediatric Nephrology and Hypertension, Pediatric Institute, Jagiellonian University Medical College, Kraków, Poland
- 700 1_
- $a Erdine, Serap $u Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Istanbul, Turkey
- 700 1_
- $a Fernandez-Aranda, Fernando $u CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain $u University Hospital of Bellvitge-IDIBELL, Barcelona, Spain $u Department of Clinical Sciences, University of Barcelona, Barcelona, Spain
- 700 1_
- $a Hadjipanayis, Adamos $u School of Medicine, European University Cyprus, Nicosia, Cyprus $u Department of Paediatrics, Larnaca General Hospital, Larnaca, Cyprus
- 700 1_
- $a Hoyer, Peter F $u Department of Pediatrics II, University Hospital Essen, Essen, Germany
- 700 1_
- $a Jankauskiene, Augustina $u Pediatric Center, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania
- 700 1_
- $a Jiménez-Murcia, Susana $u CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain $u University Hospital of Bellvitge-IDIBELL, Barcelona, Spain $u Department of Clinical Sciences, University of Barcelona, Barcelona, Spain
- 700 1_
- $a Litwin, Mieczysław $u Department of Nephrology, Kidney Transplantation and Hypertension, The Children's Memorial Health Institute, Warsaw, Poland
- 700 1_
- $a Mazur, Artur $u Institute of Medical Sciences, Medical College, Rzeszów University, Rzeszow, Poland
- 700 1_
- $a Pall, Denes $u Department of Medical Clinical Pharmacology, University of Debrecen, Debrecen, Hungary $u Department of Medicine, University of Debrecen, Debrecen, Hungary
- 700 1_
- $a Seeman, Tomas $u Division of Pediatric Nephrology, University Children's Hospital, Charles University, Prague, Czechia $u Department of Pediatrics, University Hospital Ostrava, Ostrava, Czechia
- 700 1_
- $a Sinha, Manish D $u Department of Paediatric Nephrology, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
- 700 1_
- $a Simonetti, Giacomo $u Institute of Pediatrics of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland
- 700 1_
- $a Stabouli, Stella $u 1st Department of Pediatrics, Aristotle University of Thessaloniki, Hippokratio General Hospital of Thessaloniki, Thessaloniki, Greece
- 700 1_
- $a Wühl, Elke $u Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany
- 773 0_
- $w MED00194312 $t Frontiers in pediatrics $x 2296-2360 $g Roč. 11, č. - (2023), s. 1140357
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37138561 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230707 $b ABA008
- 991 __
- $a 20230721095341 $b ABA008
- 999 __
- $a ok $b bmc $g 1958601 $s 1196275
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 11 $c - $d 1140357 $e 20230411 $i 2296-2360 $m Frontiers in pediatrics $n Front Pediatr $x MED00194312
- LZP __
- $a Pubmed-20230707
